The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adult Philadelphia-like B-cell acute lymphoblastic leukemia: Characteristics, outcomes, and role of allogeneic hematopoietic cell transplantation in comparison to Philadelphia-positive and Philadelphia-negative acute lymphoblastic leukemia.
 
Zaid Abdel Rahman
No Relationships to Disclose
 
Michael Heckman
No Relationships to Disclose
 
Theodora Anagnostou
No Relationships to Disclose
 
Launia White
No Relationships to Disclose
 
Sara M. Kloft-Nelson
No Relationships to Disclose
 
Ryan A. Knudson
No Relationships to Disclose
 
Hassan Alkhateeb
No Relationships to Disclose
 
Lisa Ostrosky Sproat
No Relationships to Disclose
 
Nandita Khera
No Relationships to Disclose
 
Hemant S. Murthy
Research Funding - crispr therapeutics (Inst)
 
Ernesto Ayala
No Relationships to Disclose
 
William J. Hogan
No Relationships to Disclose
 
Vivek Roy
No Relationships to Disclose
 
Jess Peterson
No Relationships to Disclose
 
Mohamed Kharfan-Dabaja
No Relationships to Disclose
 
Rhett P. Ketterling
No Relationships to Disclose
 
Mark Robert Litzow
Consulting or Advisory Role - Newlink Genetics; Omeros
Research Funding - Abbvie; Abbvie/Genentech; Actinium Pharmaceuticals; Amgen; Astellas Pharma; Pluristem Therapeutics; Tolero Pharmaceuticals
Other Relationship - Biosight
 
Mrinal Patnaik
Honoraria - Kura Oncology (Inst)
Consulting or Advisory Role - Kura Oncology (Inst)
Research Funding - Stemline Therapeutics (Inst)
 
James M. Foran
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Certara Inc; Novartis; Pfizer; Revolution Medicines; Revolution Medicines; Sanofi; SERVIER; Stemline Therapeutics; Syros Pharmaceuticals; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Actinium Pharmaceuticals (Inst); Aprea Therapeutics (Inst); Aptose Biosciences (Inst); Boehringer Ingelheim (Inst); H3 Biomedicine (Inst); Kura Oncology (Inst); Sellas Life Sciences (Inst); Takeda (Inst); Trillium Therapeutics (Inst); Xencor (Inst)
 
Patricia T. Greipp
No Relationships to Disclose